Wet Age-Related Macular Degeneration Market by Therapeutics, Diagnostics, Patient, Drugs Policy and Regulatory Landscape

The market is projected to generate revenue worth $10.4 billion in 2024, witnessing a CAGR of 7.1% during the forecast period (2019–2024).  AMD is a disease in which blurred vision or blindness occurs due to damage to the retina macula. Read more ›